Outcomes after surgical revascularization in diabetic patients.

Coronary artery bypass grafting diabetes mellitus endothelial damage inhibitor graft failure

Journal

Interdisciplinary cardiovascular and thoracic surgery
ISSN: 2753-670X
Titre abrégé: Interdiscip Cardiovasc Thorac Surg
Pays: England
ID NLM: 9918540787006676

Informations de publication

Date de publication:
13 Jan 2024
Historique:
received: 05 12 2023
revised: 30 12 2023
accepted: 12 01 2024
medline: 14 1 2024
pubmed: 14 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

Patients with diabetes mellitus undergoing coronary-artery bypass grafting (CABG) have been repeatedly suggested to have worse clinical outcomes compared to patients without DM. The objective of this study was to evaluate the impact of diabetes mellitus on 1-year clinical outcomes after isolated CABG. The European DuraGraft registry included 1130 patients (44.6%) with and 1402 (55.4%) patients without diabetes mellitus undergoing isolated CABG. Intra-operatively, all free venous and arterial grafts were treated with an endothelial damage inhibitor. Primary end-point in this analysis was the incidence of a major adverse cardiac event, a composite of all-cause death, repeat-revascularization or myocardial-infarction at 1-year post CABG. To balance between differences in baseline characteristics (n = 1,072 patients in each group) propensity score matching was used. Multivariable Cox proportional hazards regression was performed to identify independent predictors of major adverse cardiac events. Diabetic patients had a higher cardiovascular risk-profile and EuroScore II with overall more comorbidities. Patients were comparable in regard to surgical techniques and completeness of revascularization. At 1-year, diabetics had a higher major adverse cardiac event rate (7.9% vs 5.5%, hazard ratio (HR) 1.43 (95% CI 1.05-1.95), p = 0.02), driven by increased rates of death (5.6% vs 3.5%, HR 1.61 (95% CI 1.10-2.36), p = 0.01) and myocardial infarction (2.8% vs 1.4%, HR 1.99 (95% CI 1.12-3.53) p = 0.02). Following propensity matching, no statistically significant difference was found for major adverse cardiac events (7.1% vs 5.7%, HR 1.23 (95% CI 0.87-1.74) p = 0.23) or its components. Age, critical operative state, extracardiac arteriopathy, ejection-fraction ≤50% and left-main disease, but not diabetes mellitus were identified as independent predictors for major adverse cardiac events. In this study, 1-year outcomes in diabetics undergoing isolated CABG was comparable to patients without diabetes mellitus.

Identifiants

pubmed: 38218725
pii: 7529232
doi: 10.1093/icvts/ivae014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Auteurs

Martin Misfeld (M)

University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
Royal Prince Alfred Hospital, Sydney, Australia.
Institute of Academic Surgery at RPA, Sydney, Australia.
The Baird Institute of Applied Heart and Lung Surgical Research, Sydney, Australia.
Medical School, University of Sydney, Australia.

Sigrid Sandner (S)

Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Etem Caliskan (E)

Charité Universitätsmedizin Berlin, Berlin, Germany.
German Heart Center Berlin, Berlin, Germany.

Andreas Böning (A)

Justus Liebig University Giessen, Giessen, Germany.

Jose Aramendi (J)

Hospital de Cruces, Barakaldo, Spain.

Sacha P Salzberg (SP)

Swiss Heart Clinic, Zurich, Switzerland.

Yeong-Hoon Choi (YH)

Kerckhoff Heart Center Bad Nauheim, Campus Kerckhoff Justus-Liebig University, Giessen.

Louis P Perrault (LP)

Montreal Heart Institute, Montreal, Canada.

Ilker Tekin (I)

Manavgat Government Hospital, Manavgat, Turkey.
Bahçeşehir University Faculty of Medicine, İstanbul, Turkey.

Gregorio P Cuerpo (GP)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Jose Lopez-Menendez (J)

Hospital Universitario Ramon y Cajal, Madrid, Spain.

Luca P Weltert (LP)

European Hospital, Rome, Italy.

Alejandro Adsuar-Gomez (A)

Virgen del Rocio University Hospital, Seville, Spain.

Matthias Thielmann (M)

West-German Heart and Vascular Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Giuseppe F Serraino (GF)

Magna Graecia University Of Catanzaro, Catanzaro, Italy.

Gheorghe Doros (G)

Boston University, Boston, MA, USA.

Michael A Borger (MA)

University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Maximilian Y Emmert (MY)

Charité Universitätsmedizin Berlin, Berlin, Germany.
German Heart Center Berlin, Berlin, Germany.

Classifications MeSH